The shifting patterns of HIV encephalitis neuropathology

被引:93
作者
Everall, IP
Hansen, LA
Masliah, E [1 ]
机构
[1] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
关键词
HIV; encephalitis; HAART; chronic; opportunistic infections; HCV; methamphetamine; white matter; amyloid;
D O I
10.1007/BF03033819
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
HIV infected macrophages infiltrate the nervous system early in the progression of HIV infection, leading to a complex set of neuropathological alterations including HIV encephalitis (HIVE), leukoencephalopathy and vacuolar myelopathy. This in turn results in neurodegeneration of selective cellular populations and pathways involved in regulating cognitive and motor functioning. Rapid progress in the development of highly active antiretroviral therapy (HAART) has changed the patterns of HIV related neuropathology and neurological manifestations in the past 10 years. The prevalence of opportunistic infections and central nervous system (CNS) neoplasms has decreased, and some groups have proposed that the frequency of chronic forms of HIVE have been rising as the HAART-treated HIV population ages. Accordingly, clinical manifestations have shifted from severe dementia forms to more subtle minor cognitive impairment, leading to the suggestion of a classification of HIV associated neurological conditions into an inactive form, a chronic variety, and a 'transformed' variant. From a neuropathological point of view these variants might correspond to: a) aggressive forms with severe HIVE and white matter injury, b) extensive perivascular lymphocytic infiltration, c) 'burnt-out' forms of HIVE and d) aging-associated amyloid accumulation with Alzheimer's-like neuropathology. Factors contributing to the emergence of these variants of HIVE include the development of viral resistance, immune reconstitution, anti-retroviral drug toxicity and co-morbid factors (e.g., methamphetamine, HCV). More detailed characterization of these proposed variants of HIVE is important in order to better understand the pathogenesis of HIV-associated neurological damage and to design more effective treatments to protect the nervous system.
引用
收藏
页码:51 / 61
页数:11
相关论文
共 126 条
[1]   QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS, IMMUNE ACTIVATION FACTORS, AND QUINOLINIC ACID IN AIDS BRAINS [J].
ACHIM, CL ;
HEYES, MP ;
WILEY, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2769-2775
[2]   Immunopathogenesis of HIV Encephalitis [J].
Achim, Cristian L. ;
Schrier, Rachel D. ;
Wiley, Clayton A. .
BRAIN PATHOLOGY, 1991, 1 (03) :177-184
[3]   NEURONAL APOPTOSIS IN HIV-INFECTION IN ADULTS [J].
ADLEBIASSETTE, H ;
LEVY, Y ;
COLOMBEL, M ;
PORON, F ;
NATCHEV, S ;
KEOHANE, C ;
GRAY, F .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1995, 21 (03) :218-227
[4]   AIDS-related focal brain lesions in the era of highly active antiretroviral therapy [J].
Ammassari, A ;
Cingolani, A ;
Pezzotti, P ;
De Luca, A ;
Murri, R ;
Giancola, ML ;
Larocca, LM ;
Antinori, A .
NEUROLOGY, 2000, 55 (08) :1194-1200
[5]   Changing disease patterns in focal brain lesion-causing disorders in AIDS [J].
Ammassari, A ;
Scoppettuolo, G ;
Murri, R ;
Pezzotti, P ;
Cingolani, A ;
Del Borgo, C ;
De Luca, A ;
Antinori, A ;
Ortona, L .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (04) :365-371
[6]   Relationship of Nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection [J].
Anderson, CE ;
Tomlinson, GS ;
Pauly, B ;
Brannan, FW ;
Chiswick, A ;
Brack-Werner, R ;
Simmonds, P ;
Bell, JE .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (04) :378-388
[7]   Influence of HAART on HIV-related CNS disease and neuroinflammation [J].
Anthony, IC ;
Ramage, SN ;
Carnie, FW ;
Simmonds, P ;
Bell, JE .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (06) :529-536
[8]   Role of brain biopsy in the management of focal brain lesions in HIV-infected patients [J].
Antinori, A ;
Ammassari, A ;
Luzzati, R ;
Castagna, A ;
Maserati, R ;
Rizzardini, G ;
Ridolfo, A ;
Fasan, M ;
Vaccher, E ;
Landonio, G ;
Scerrati, M ;
Rocca, A ;
Butti, G ;
Nicolato, A ;
Lazzarin, A ;
Tirelli, U .
NEUROLOGY, 2000, 54 (04) :993-997
[9]   HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment [J].
Arese, M ;
Ferrandi, C ;
Primo, L ;
Camussi, G ;
Bussolino, F .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1380-1388
[10]  
Asare E, 1996, AM J PATHOL, V148, P31